Search dm+d | This AMP cannot be matched against our prescribing data.
Description | COVID-19 Vaccine Nuvaxovid (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials (Novavax CZ a.s.) |
BNF code | 1404000ATBEAAAD |
Virtual Medicinal Product | Generic COVID-19 Vaccine Nuvaxovid (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials |
Name | COVID-19 Vaccine Nuvaxovid (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials |
Abbreviated name | COVID-19 Vaccine Nuvaxovid 0.5ml inj multidose vials |
Date of name applicability | 23 Feb 2022 |
Previous name | COVID-19 Vaccine Novavax (adjuvanted) 5micrograms/0.5ml dose suspension for injection multidose vials |
Supplier | Novavax CZ a.s. |
Current licensing authority | Medicines - MHRA/EMA |
Previous licensing authority | None |
Reason for change of licensing authority | Licence Granted |
Date of change of licensing authority | 23 Feb 2022 |
EMA additional monitoring | ✓ |
Parallel import | ✗ |
Restrictions on availability | Restricted Availability |
Licensed Route | |
---|---|
Licenced route | Intramuscular |
Actual Medicinal Product Packs | |
COVID-19 Vaccine Nuvaxovid (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials (Novavax CZ a.s.) 100 dose 10 x 10 dose vials | |
COVID-19 Vaccine Nuvaxovid (recombinant, adjuvanted) 5micrograms/0.5ml dose dispersion for injection multidose vials (Novavax CZ a.s.) 10 dose |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.